Dilacor XR Trademark Details

Dilacor Xr was registered on Tuesday, October 27, 1992 and is currently owned by Watson Laboratories, Inc. under the registration number 1726980 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 11 years ago on Thursday, June 28, 2012, according to the United State Patent & Trademark Office
Word Mark Dilacor Xr
Status Alive Registered 800 — Registered and Renewed

Current Owner

Watson Laboratories, Inc. of Parsippany, NJ

View all trademarks for Watson Laboratories, Inc.
Other Trademarks for Watson Laboratories, Inc.

Previous Owners

Rhone-Poulenc Rorer Pharmaceuticals Inc. of Collegeville, PA

View all trademarks for Rhone-Poulenc Rorer Pharmaceuticals Inc.
Other Trademarks for Rhone-Poulenc Rorer Pharmaceuticals Inc.
Serial Number 74249539
Registration Number 1726980
Status Date Thursday, June 28, 2012
Filing Date Thursday, June 28, 2012
Registration Date Tuesday, October 27, 1992
Attorney Stephanie K Wade

Correspondent

STEPHANIE K. WADE
SUGHRUE MION, PLLC
2100 PENNSYLVANIA AVE. NW
WASHINGTON DC 20037

Case File Statements

Goods & Services Cardiovascular Preparation Particularly Useful for the Treatment of Hypertension

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 6 — Active
Status Date Tuesday, March 31, 1992
First Use Anywhere Thursday, October 3, 1991
First Use In Commerce Thursday, October 3, 1991
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.